Cairo – Mubasher: Arab Drug Company reported a 10.12% year-on-year (YoY) growth in its pre-tax net profits, logging EGP 103.39 million during the first nine months of fiscal year 2020/2021, compared to EGP 93.88 million, the unaudited financial results showed.
The sales increased to EGP 422.08 million from July 2020 to March 2021, compared to EGP 413.57 million in the same period of FY19/20, the company said in a bourse disclosure on Sunday.
During the first half (H1) of FY20/21, the company's net profits rose to EGP 58.31 million, compared to EGP 45.11 million in the corresponding period a year earlier.
